Results 251 to 260 of about 42,521 (302)

Differential association of hyperglucagonemia with C-peptide levels in diabetic ketosis/ketoacidosis and hyperosmolar hyperglycemic state. [PDF]

open access: yesDiabetol Int
Iida T   +10 more
europepmc   +1 more source

Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification. [PDF]

open access: yesSmall Sci
DeWolf EL   +7 more
europepmc   +1 more source

Deciphering obesity: a conceptual overview and synthesis. [PDF]

open access: yesFront Endocrinol (Lausanne)
Prakash R, Arora A, Khan A.
europepmc   +1 more source

Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation. [PDF]

open access: yesMedicine (Baltimore)
Alansari AO   +10 more
europepmc   +1 more source

Human Islet

open access: yes
Cell Proliferation, EarlyView.
Jiaqi Zou   +31 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Glucagon-like peptides

Diabetes, 1998
Proglucagon contains the sequence of two glucagonlike peptides, GLP-1 and GLP-2, secreted from enteroendocrine cells of the small and large intestine. GLP-1 lowers blood glucose in both NIDDM and IDDM patients and may be therapeutically useful for treatment of patients with diabetes.
Daniel J Drucker, Jens J Holst Dmsci
openaire   +4 more sources

Glucagon-Like Peptide-2

Annual Review of Nutrition, 2006
▪ Abstract  Multiple peptide hormones produced within the gastrointestinal system aid in the regulation of energy homeostasis and metabolism. Among these is the intestinotrophic peptide glucagon-like peptide-2 (GLP-2), which is released following food intake and plays a significant role in the adaptive regulation of bowel mass and mucosal integrity ...
Jennifer L, Estall, Daniel J, Drucker
openaire   +2 more sources

Glucagon-like peptide-1 and glucagon-like peptide-2

Best Practice & Research Clinical Endocrinology & Metabolism, 2004
The glucagon-like peptides (glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2)) are released from enteroendocrine cells in response to nutrient ingestion. GLP-1 enhances glucose-stimulated insulin secretion and inhibits glucagon secretion, gastric emptying and feeding. GLP-1 also has proliferative, neogenic and antiapoptotic effects on
Laurie L. Baggio, Daniel J. Drucker
openaire   +1 more source

Home - About - Disclaimer - Privacy